Eczema Care - DermaTherapy® Bedding

REVOLUTIONARY NEW BEDDING DEVELOPED FOR SUFFERERS OF ECZEMA

The first bedding to be approved by the American FDA as a Class 1 Medical Device is now available from Espère Healthcare Ltd.

DermaTherapy® bedding is designed to minimize friction with the skin, unlike cotton and poly-cotton sheets which have microscopic protruding fibres that can irritate the skin, particularly when they become damp.

DermaTherapy® bedding is made from uniquely structured continuous filament yarns that are woven in such a way as to create micro-channels that effectively dissipate heat and wick moisture away from the skin and distribute it evenly over the whole surface of the sheet where it quickly evaporates. This patent-pending new development in fabric technology results in a cleaner, drier and smoother sleeping surface.

DermaTherapy® bedding has a durable antimicrobial treatment permanently bonded into the fabric to help maintain the fabrics freshness and eliminates odours caused by bacteria and fungi PLUS a ‘soil release’ finish to help remove oils, creams, blood and other stains.

DermaTherapy® bedding is also dust and lint-free which means that it does not shed fibre particles that could irritate the skin and bronchial airways and can be washed at high temperatures if required.

Compared to cotton bedding, DermaTherapy sheets are:

• 29% lighter
• 43% thinner
• 53% more supple
• 37% smoother
• Restores dryness in 25 minutes

The development of this fabric technology results in a cleaner, drier, smoother and more comfortable sleeping surface, and with an average pore size of just 8.5 microns, DermaTherapy® bedding has the added advantage of helping to protect against dust mites. For those who suffer from skin conditions or tend to sweat and overheat at night – the difference is truly remarkable.


The information contained on this page has been provided by Espère Healthcare Ltd

Page created: 9 June 2008